Canadian Agency for Drugs and Technologies in Health. (2018). Pharmacoeconomic review report: Glecaprevir / pibrentasvir (Maviret) (AbbVie corporation). CADTH.
Chicago Style (17th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Glecaprevir / Pibrentasvir (Maviret) (AbbVie Corporation). Ottawa (ON): CADTH, 2018.
MLA (9th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Glecaprevir / Pibrentasvir (Maviret) (AbbVie Corporation). CADTH, 2018.
Warning: These citations may not always be 100% accurate.